While growing evidence highlights the benefits of green and blue spaces for physical and mental health, their combined effects on youth visual acuity remain unclear. This study aimed to evaluate the associations of green and blue spaces with visual acuity in youths. We analyzed data from the 2023 Common Disease and Health Risk Factors Surveillance and Intervention Program among students in Shandong Province, China. Generalized linear mixed-effects models were employed to investigate the independent associations of green and blue spaces with visual acuity in youths. To explore potential interactions, an interaction term for green and blue spaces was incorporated. Quantile g-computation (Qgcomp) models were applied to evaluate their combined effects. Compared to the lowest quartile, higher quartiles (Q2, Q3, and Q4) of the normalized difference vegetation index (NDVI), enhanced vegetation index (EVI), normalized difference water index (NDWI), and modified normalized difference water index (MNDWI) were significantly associated with improved visual acuity in both eyes. Additionally, each 0.1 unit increase in NDVI500, EVI500, NDWI500, and MNDWI500 was associated with 0.008 (95 % confidence interval [CI]: 0.007, 0.010), 0.003 (0.002, 0.004), 0.054 (0.028, 0.080), and 0.010 (0.002, 0.018) improvements in right-eye visual acuity, with similar findings for the left eye. A significant interaction was observed between NDVI and NDWI (all P for interaction < 0.001), and combined exposure to green and blue spaces was positively associated with visual acuity (all P < 0.001). Furthermore, demographic and lifestyle factors modified the associations of blue and green spaces with visual acuity levels in youths. Greater exposure to green and blue spaces may benefit visual health in youths, with potential interactive and combined effects. Implementing policies to enhance the availability of green and blue spaces around schools may offer opportunities to alleviate visual impairment in youths.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ecoenv.2025.117947 | DOI Listing |
Cornea
March 2025
Department of Ophthalmology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Purpose: To evaluate the effect of customized corneal crosslinking on pellucid marginal degeneration (PMD).
Methods: Twenty-eight eyes with PMD were included. Fifteen eyes were treated with customized corneal crosslinking at Helsinki University Eye Hospital.
Int Ophthalmol
March 2025
Burapha University Hospital, Burapha University, Saen Suk, Chonburi, Thailand.
Background: Retinitis pigmentosa (RP) is a retinal dystrophy and genetically heterogeneous group that causes vision loss and necessitates innovative therapeutic strategies, and mesenchymal stem cell (MSC) therapy has shown potential due to its regenerative and immunomodulatory properties. This meta-analysis aims to evaluate the efficacy and safety of MSC therapies in improving visual outcomes, focusing on the impact of various MSC types, administration methods, and duration of benefits.
Methods: A systematic search of peer-reviewed studies was conducted to identify clinical trials and observational studies investigating MSC therapies for retinal conditions.
Doc Ophthalmol
March 2025
Department of Ophthalmology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Purpose: To report our flicker electroretinographic (ERG) findings in a patient who developed uveitis after treatment with immune checkpoint inhibitors (ICIs) for a metastatic malignant melanoma.
Methods: ERGs were used to monitor retinal physiology in a patient with ocular complications following systemic ICI administration. Flicker ERGs were recorded using the RETeval system before and after the ICI treatments.
Invest Ophthalmol Vis Sci
March 2025
College of Optometry, Nova Southeastern University, Davie, Florida, United States.
Purpose: The purpose of this study was to quantify the corneal power changes after wearing orthokeratology lenses of different back optic zone diameters (BOZDs) and to propose a novel 4-parameter model capable of revealing the associations between each parameter and axial length growth (ALG).
Methods: A prospective self-controlled study was conducted between June 2022 and December 2023. One eye in each subject (N = 33) was randomly assigned to wear a lens with a BOZD of either 5 mm (5 oz) or 6 mm (6 oz).
J Glaucoma
March 2025
Department of Ophthalmology, National University Hospital, National University Health System.
Prcis: In this retrospective cohort study, the 1-year cumulative probability of failure was comparable, achieving 52.20% in the phacoemulsification-iStent inject W (phaco/iStent) group and 47.80% in the phacoemulsification-micropulse transscleral laser therapy (phaco/MPTLT) group (P=0.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!